PT-141 (bremelanotide) — an MC4R-preferential melanocortin agonist — research reference for Australia laboratory work.
PT-141 (bremelanotide) is a synthetic peptide derived from Melanotan 2 with melanocortin-receptor selectivity favoring MC4R. Published Australia literature characterizes both pharmacokinetics and behavioral assay endpoints.
Research use only. Pure Peptides supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
